RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. KaliVir Immunotherapeutics

KaliVir Immunotherapeutics

multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer.

Latest funding

$14M Series A ·

Source: fundraisingfox.com

Funding history ↓
Website: kalivir.com.
X: @kalivir_immuno · 75 followers.
Category: Health and bio.
Stage: Series A.
Last round: Aug 19, 2026 · 89 days ago.
On Recent Funding since: Sep 29, 2026.

Signals

X account@kalivir_immuno · created Jul 31, 2020 (6 years old) · 75 followers
Website registeredJun 19, 2019 (7 years old)
TIMELINE · MONEY RAISED

KaliVir Immunotherapeutics | 2618 days from website to first raise on record

@kalivir_immuno·Raised $14M in 1 sourced round·2 signals before the first raise
$3.5M$7.0M$11M$14MJULJULJULJULJULJULJULJUL$14M||WEBSITE CREATED · JUN 19, 2019||X ACCOUNT CREATED @KALIVIR_IMMUNO · JUL 31, 2020$14M Series A · Aug 19, 2026$14M A · AUG '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series A$14M—fundraisingfox.com

Timeline

  1. X account created
  2. Website created

Companies like KaliVir Immunotherapeutics

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kalivir-immunotherapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy